Johnson & Johnson orthopedics sales up 3.5% in Q1: 4 notes

Spinal Tech

Johnson & Johnson saw first-quarter revenue rise 5 percent, with growth in its orthopedics sales.

Four things to know:

1. Global orthopedic sales were $2.2 billion, an increase of 3.5 percent year over year, according to financial results posted April 19. U.S. sales rose 3.2 percent year over year, netting $1.3 billion.

2. Global hip and knee sales increased 9.3 percent and 6.7 percent year over year, respectively. Hip sales were $389 million and knee sales were $339 million.

3. The spine and sports segment saw an increase of less than 1 percent in the first quarter compared to the same period last year with $712 million in revenue. The trauma segment saw global sales of $748 million, a 2.1 percent increase year over year, the report said.

4. The company's full first-quarter sales were $23.4 billion, an increase of 5 percent compared to the first quarter of 2021.

Copyright © 2025 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


You can unsubscribe from these communications at any time. For more information, please review our Privacy Policy.
 

Articles We Think You'll Like